SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-003973
Filing Date
2018-05-15
Accepted
2018-05-15 16:47:15
Documents
68
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051518p.htm 10-Q 784482
2 EXHIBIT 10.4 exh_104.htm EX-10.4 6183
3 EXHIBIT 21.1 exh_211.htm EX-21.1 2366
4 EXHIBIT 31.1 exh_311.htm EX-31.1 6816
5 EXHIBIT 31.2 exh_312.htm EX-31.2 6949
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3961
  Complete submission text file 0001171843-18-003973.txt   5410515

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE args-20180331.xml EX-101.INS 900021
8 XBRL SCHEMA FILE args-20180331.xsd EX-101.SCH 69412
9 XBRL CALCULATION FILE args-20180331_cal.xml EX-101.CAL 31256
10 XBRL DEFINITION FILE args-20180331_def.xml EX-101.DEF 504898
11 XBRL LABEL FILE args-20180331_lab.xml EX-101.LAB 408582
12 XBRL PRESENTATION FILE args-20180331_pre.xml EX-101.PRE 519100
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35443 | Film No.: 18837337
SIC: 2834 Pharmaceutical Preparations